Product Code: GVR-4-68038-416-1
Intracranial Aneurysm Market Growth & Trends:
The global intracranial aneurysm market size is anticipated to reach USD 2.74 billion in 2030 and is projected to grow at a CAGR of 9.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to various factors, such as increased cases of stroke, increasing incidence of people suffering from cerebrovascular disorders, and continuous product launches by key players. Furthermore, the market is growing rapidly in developing nations with expanding disposable income levels and improved access to healthcare. Currently, the cause of brain aneurysms is not clearly understood. However, there are various factors linked to this condition, including aging, brain trauma, hereditary, high blood pressure, atherosclerosis, infections, and a sedentary lifestyle. Notable symptoms encompass cranial nerve dysfunction, localized headaches, and double vision.
Consequently, the growing population of individuals afflicted with intracranial aneurysms is contributing to the market expansion. Businesses in this field are always looking for ways to make existing therapies safer and more effective while also introducing new technologies, which are anticipated to increase the demand for intracranial aneurysm products globally. For instance, in June 2022, Pipeline Vantage with Shield Technology, a fourth-generation flow deflector with a CE mark by India Medtronic, was developed for endovascular therapy for cerebral aneurysms. A newly developed flow deflector, Pipeline Vantage, features Shield technology and has enhanced features of the design for both the delivery system and the implant. By developing a scaffold that promotes the development of cells in the innermost layer of the target blood vessel, these qualities make it easier and more reliable for doctors to deliver, deploy, and repair brain aneurysms and intracranial aneurysms.
Intracranial Aneurysm Market Report Highlights:
- The global market has experienced a significant degree of innovation, with innovations in both endovascular devices and delivery systems.
- The endovascular coiling segment led the market with the largest revenue share of 72.4% in 2024. The endovascular coiling technique is a minimally invasive procedure that employs a catheter to identify and treat aneurysms in the brain.
- The flow diverters segment is expected to grow at the fastest CAGR of 13.4% over the forecast period. The continuous evolution of flow diverter technology boosts the market growth.
- The hospital segment dominated the global intracranial aneurysm market and accounted for the largest revenue share of 88.9% in 2024.
- North America intracranial aneurysm market dominated the global market and accounted for the largest revenue share of 27.6% in 2024 owing to the presence of well-established healthcare infrastructure, the rising geriatric population, and the high incidence of hypertension and stroke.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. End Use
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
- 1.5. Information or Data Analysis
- 1.5.1. Data Analysis Models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.8. List of Secondary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type Outlook
- 2.2.2. End Use Outlook
- 2.2.3. Regional Outlook
- 2.3. Competitive Insights
Chapter 3. Global Intracranial Aneurysm Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Global Intracranial Aneurysm Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political Landscape
- 3.3.2.2. Technological Landscape
- 3.3.2.3. Economic Landscape
Chapter 4. Global Intracranial Aneurysm Market: Type Business Analysis
- 4.1. Type Segment Dashboard
- 4.2. Intracranial Aneurysm Market: Type Movement Analysis
- 4.3. Global Intracranial Aneurysm Market Size & Trend Analysis, By Type, 2018 to 2030 (USD Million)
- 4.4. Surgical Clipping
- 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 4.5. Endovascular Coiling
- 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 5. Global Intracranial Aneurysm Market: End Use Business Analysis
- 5.1. End Use Segment Dashboard
- 5.2. Intracranial Aneurysm Market: End Use Movement Analysis
- 5.3. Global Intracranial Aneurysm Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
- 5.4. Hospitals
- 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 5.5. Clinics
- 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 5.6. Others
- 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 6. Global Intracranial Aneurysm Market: Regional Estimates & Trend Analysis
- 6.1. Regional Market Dashboard
- 6.2. Regional Market Share Analysis, 2024 & 2030
- 6.3. Global Intracranial Aneurysm Market by Regional: Key Takeaways
- 6.4. North America
- 6.4.1. U.S.
- 6.4.1.1. Key Country Dynamics
- 6.4.1.2. Regulatory Framework/ Reimbursement Structure
- 6.4.1.3. Competitive Scenario
- 6.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.4.2. Canada
- 6.4.2.1. Key Country Dynamics
- 6.4.2.2. Regulatory Framework/ Reimbursement Structure
- 6.4.2.3. Competitive Scenario
- 6.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.4.3. Mexico
- 6.4.3.1. Key Country Dynamics
- 6.4.3.2. Regulatory Framework/ Reimbursement Structure
- 6.4.3.3. Competitive Scenario
- 6.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.5. Europe
- 6.5.1. Germany
- 6.5.1.1. Key Country Dynamics
- 6.5.1.2. Regulatory Framework/ Reimbursement Structure
- 6.5.1.3. Competitive Scenario
- 6.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.5.2. UK
- 6.5.2.1. Key Country Dynamics
- 6.5.2.2. Regulatory Framework/ Reimbursement Structure
- 6.5.2.3. Competitive Scenario
- 6.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.5.3. France
- 6.5.3.1. Key Country Dynamics
- 6.5.3.2. Regulatory Framework/ Reimbursement Structure
- 6.5.3.3. Competitive Scenario
- 6.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.5.4. Italy
- 6.5.4.1. Key Country Dynamics
- 6.5.4.2. Regulatory Framework/ Reimbursement Structure
- 6.5.4.3. Competitive Scenario
- 6.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.5.5. Spain
- 6.5.5.1. Key Country Dynamics
- 6.5.5.2. Regulatory Framework/ Reimbursement Structure
- 6.5.5.3. Competitive Scenario
- 6.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.5.6. Denmark
- 6.5.6.1. Key Country Dynamics
- 6.5.6.2. Regulatory Framework/ Reimbursement Structure
- 6.5.6.3. Competitive Scenario
- 6.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.5.7. Sweden
- 6.5.7.1. Key Country Dynamics
- 6.5.7.2. Regulatory Framework/ Reimbursement Structure
- 6.5.7.3. Competitive Scenario
- 6.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.5.8. Norway
- 6.5.8.1. Key Country Dynamics
- 6.5.8.2. Regulatory Framework/ Reimbursement Structure
- 6.5.8.3. Competitive Scenario
- 6.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.6. Asia Pacific
- 6.6.1. Japan
- 6.6.1.1. Key Country Dynamics
- 6.6.1.2. Regulatory Framework/ Reimbursement Structure
- 6.6.1.3. Competitive Scenario
- 6.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.6.2. China
- 6.6.2.1. Key Country Dynamics
- 6.6.2.2. Regulatory Framework/ Reimbursement Structure
- 6.6.2.3. Competitive Scenario
- 6.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.6.3. India
- 6.6.3.1. Key Country Dynamics
- 6.6.3.2. Regulatory Framework/ Reimbursement Structure
- 6.6.3.3. Competitive Scenario
- 6.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.6.4. Australia
- 6.6.4.1. Key Country Dynamics
- 6.6.4.2. Regulatory Framework/ Reimbursement Structure
- 6.6.4.3. Competitive Scenario
- 6.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.6.5. Thailand
- 6.6.5.1. Key Country Dynamics
- 6.6.5.2. Regulatory Framework/ Reimbursement Structure
- 6.6.5.3. Competitive Scenario
- 6.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.6.6. South Korea
- 6.6.6.1. Key Country Dynamics
- 6.6.6.2. Regulatory Framework/ Reimbursement Structure
- 6.6.6.3. Competitive Scenario
- 6.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.7. Latin America
- 6.7.1. Brazil
- 6.7.1.1. Key Country Dynamics
- 6.7.1.2. Regulatory Framework/ Reimbursement Structure
- 6.7.1.3. Competitive Scenario
- 6.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.7.2. Argentina
- 6.7.2.1. Key Country Dynamics
- 6.7.2.2. Regulatory Framework/ Reimbursement Structure
- 6.7.2.3. Competitive Scenario
- 6.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.8. Middle East & Africa
- 6.8.1. South Africa
- 6.8.1.1. Key Country Dynamics
- 6.8.1.2. Regulatory Framework/ Reimbursement Structure
- 6.8.1.3. Competitive Scenario
- 6.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.8.2. Saudi Arabia
- 6.8.2.1. Key Country Dynamics
- 6.8.2.2. Regulatory Framework/ Reimbursement Structure
- 6.8.2.3. Competitive Scenario
- 6.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.8.3. UAE
- 6.8.3.1. Key Country Dynamics
- 6.8.3.2. Regulatory Framework/ Reimbursement Structure
- 6.8.3.3. Competitive Scenario
- 6.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 6.8.4. Kuwait
- 6.8.4.1. Key Country Dynamics
- 6.8.4.2. Regulatory Framework/ Reimbursement Structure
- 6.8.4.3. Competitive Scenario
- 6.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.3. Vendor Landscape
- 7.3.1. Key Company Heat Map Analysis, 2024
- 7.4. Company Profiles
- 7.4.1. Medtronic plc
- 7.4.1.1. Company Overview
- 7.4.1.2. Financial Performance
- 7.4.1.3. Product Benchmarking
- 7.4.1.4. Strategic Initiatives
- 7.4.2. Stryker Corporation
- 7.4.2.1. Company Overview
- 7.4.2.2. Financial Performance
- 7.4.2.3. Product Benchmarking
- 7.4.2.4. Strategic Initiatives
- 7.4.3. MicroPort Scientific Corporation.
- 7.4.3.1. Company Overview
- 7.4.3.2. Financial Performance
- 7.4.3.3. Product Benchmarking
- 7.4.3.4. Strategic Initiatives
- 7.4.4. Johnson & Johnson Services, Inc.
- 7.4.4.1. Company Overview
- 7.4.4.2. Financial Performance
- 7.4.4.3. Product Benchmarking
- 7.4.4.4. Strategic Initiatives
- 7.4.5. MicroVention Inc.
- 7.4.5.1. Company Overview
- 7.4.5.2. Financial Performance
- 7.4.5.3. Product Benchmarking
- 7.4.5.4. Strategic Initiatives
- 7.4.6. B. Braun Melsungen AG
- 7.4.6.1. Company Overview
- 7.4.6.2. Financial Performance
- 7.4.6.3. Product Benchmarking
- 7.4.6.4. Strategic Initiatives
- 7.4.7. Integra LifeSciences
- 7.4.7.1. Company Overview
- 7.4.7.2. Financial Performance
- 7.4.7.3. Product Benchmarking
- 7.4.7.4. Strategic Initiatives
- 7.4.8. RAUMEDIC AG
- 7.4.8.1. Company Overview
- 7.4.8.2. Financial Performance
- 7.4.8.3. Product Benchmarking
- 7.4.8.4. Strategic Initiative
- 7.4.9. Terumo Corporation
- 7.4.9.1. Company Overview
- 7.4.9.2. Financial Performance
- 7.4.9.3. Product Benchmarking
- 7.4.9.4. Strategic Initiatives
- 7.4.10. Delta Surgical
- 7.4.10.1. Company Overview
- 7.4.10.2. Financial Performance
- 7.4.10.3. Product Benchmarking
- 7.4.10.4. Strategic Initiatives